Prevention of Haemophilus influenzae type b disease

This publication has 24 references indexed in Scilit:

• Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose
  The Journal of Pediatrics, 1991
• Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population
  The Pediatric Infectious Disease Journal, 1991
• Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy
  The Pediatric Infectious Disease Journal, 1991
• The Immunogenicity of Hemophilus influenzae Type B Polysaccharide--Neisseria meningitidis Group B Outer Membrane Protein Complex Vaccine in Infants and Young Children
  The Journal of Infectious Diseases, 1989
• Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine
  The Journal of Pediatrics, 1989
• Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children
  The Journal of Pediatrics, 1988
• Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine
  The Journal of Pediatrics, 1987
• Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune Globulin
  New England Journal of Medicine, 1987
• Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age
  The Journal of Pediatrics, 1986
• Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b
  The Journal of Pediatrics, 1985